Literature DB >> 28054576

Acute coronary syndromes in 2016: Assessing strategies to improve patient management.

Ron Waksman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28054576     DOI： 10.1038/nrcardio.2016.210

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  9 in total

1.  Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial.

Authors:  Henning Kelbæk; Dan Eik Høfsten; Lars Køber; Steffen Helqvist; Lene Kløvgaard; Lene Holmvang; Erik Jørgensen; Frants Pedersen; Kari Saunamäki; Ole De Backer; Lia E Bang; Klaus F Kofoed; Jacob Lønborg; Kiril Ahtarovski; Niels Vejlstrup; Hans E Bøtker; Christian J Terkelsen; Evald H Christiansen; Jan Ravkilde; Hans-Henrik Tilsted; Anton B Villadsen; Jens Aarøe; Svend E Jensen; Bent Raungaard; Lisette O Jensen; Peter Clemmensen; Peer Grande; Jan K Madsen; Christian Torp-Pedersen; Thomas Engstrøm
Journal:  Lancet       Date:  2016-04-03       Impact factor: 79.321

2.  Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial.

Authors:  Guillaume Cayla; Thomas Cuisset; Johanne Silvain; Florence Leclercq; Stephane Manzo-Silberman; Christophe Saint-Etienne; Nicolas Delarche; Anne Bellemain-Appaix; Grégoire Range; Rami El Mahmoud; Didier Carrié; Loic Belle; Geraud Souteyrand; Pierre Aubry; Pierre Sabouret; Xavier Halna du Fretay; Farzin Beygui; Jean-Louis Bonnet; Benoit Lattuca; Christophe Pouillot; Olivier Varenne; Ziad Boueri; Eric Van Belle; Patrick Henry; Pascal Motreff; Simon Elhadad; Joe-Elie Salem; Jérémie Abtan; Hélène Rousseau; Jean-Philippe Collet; Eric Vicaut; Gilles Montalescot
Journal:  Lancet       Date:  2016-08-28       Impact factor: 79.321

3.  Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study.

Authors:  Lars Wallentin; Lars Lindhagen; Elisabet Ärnström; Steen Husted; Magnus Janzon; Søren Paaske Johnsen; Frederic Kontny; Tibor Kempf; Lars-Åke Levin; Bertil Lindahl; Mats Stridsberg; Elisabeth Ståhle; Per Venge; Kai C Wollert; Eva Swahn; Bo Lagerqvist
Journal:  Lancet       Date:  2016-08-29       Impact factor: 79.321

4.  Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease.

Authors:  L Wallentin; B Lagerqvist; S Husted; F Kontny; E Ståhle; E Swahn
Journal:  Lancet       Date:  2000-07-01       Impact factor: 79.321

5.  Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.

Authors:  Matthew J Price; Peter B Berger; Paul S Teirstein; Jean-François Tanguay; Dominick J Angiolillo; Douglas Spriggs; Sanjeev Puri; Mark Robbins; Kirk N Garratt; Olivier F Bertrand; Michael E Stillabower; Michael E Stillablower; Joseph R Aragon; David E Kandzari; Curtiss T Stinis; Michael S Lee; Steven V Manoukian; Christopher P Cannon; Nicholas J Schork; Eric J Topol
Journal:  JAMA       Date:  2011-03-16       Impact factor: 56.272

6.  Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study.

Authors:  Zuzana Motovska; Ota Hlinomaz; Roman Miklik; Milan Hromadka; Ivo Varvarovsky; Jaroslav Dusek; Jiri Knot; Jiri Jarkovsky; Petr Kala; Richard Rokyta; Frantisek Tousek; Petra Kramarikova; Bohumil Majtan; Stanislav Simek; Marian Branny; Jan Mrozek; Pavel Cervinka; Jiri Ostransky; Petr Widimsky
Journal:  Circulation       Date:  2016-08-30       Impact factor: 29.690

7.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Authors:  Lars Wallentin; Richard C Becker; Andrzej Budaj; Christopher P Cannon; Håkan Emanuelsson; Claes Held; Jay Horrow; Steen Husted; Stefan James; Hugo Katus; Kenneth W Mahaffey; Benjamin M Scirica; Allan Skene; Philippe Gabriel Steg; Robert F Storey; Robert A Harrington; Anneli Freij; Mona Thorsén
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

8.  Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.

Authors:  Matthew T Roe; Paul W Armstrong; Keith A A Fox; Harvey D White; Dorairaj Prabhakaran; Shaun G Goodman; Jan H Cornel; Deepak L Bhatt; Peter Clemmensen; Felipe Martinez; Diego Ardissino; Jose C Nicolau; William E Boden; Paul A Gurbel; Witold Ruzyllo; Anthony J Dalby; Darren K McGuire; Jose L Leiva-Pons; Alexander Parkhomenko; Shmuel Gottlieb; Gracita O Topacio; Christian Hamm; Gregory Pavlides; Assen R Goudev; Ali Oto; Chuen-Den Tseng; Bela Merkely; Vladimir Gasparovic; Ramon Corbalan; Mircea Cinteză; R Craig McLendon; Kenneth J Winters; Eileen B Brown; Yuliya Lokhnygina; Philip E Aylward; Kurt Huber; Judith S Hochman; E Magnus Ohman
Journal:  N Engl J Med       Date:  2012-08-25       Impact factor: 91.245

9.  Bedside monitoring to adjust antiplatelet therapy for coronary stenting.

Authors:  Jean-Philippe Collet; Thomas Cuisset; Grégoire Rangé; Guillaume Cayla; Simon Elhadad; Christophe Pouillot; Patrick Henry; Pascal Motreff; Didier Carrié; Ziad Boueri; Loic Belle; Eric Van Belle; Hélène Rousseau; Pierre Aubry; Jacques Monségu; Pierre Sabouret; Stephen A O'Connor; Jérémie Abtan; Mathieu Kerneis; Christophe Saint-Etienne; Olivier Barthélémy; Farzin Beygui; Johanne Silvain; Eric Vicaut; Gilles Montalescot
Journal:  N Engl J Med       Date:  2012-11-04       Impact factor: 91.245
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.